2026-07-30T13:16:11-05:00 2025-12-31 390974031 WEGNER CPAS LLP 419 N LEE ST ALEXANDRIA VA 223142301 990 2025-01-01 131691693 ASTHMA AND ALLERGY FOUNDATION OF AMERICA INC ASTH 8007278462 1400 CRYSTAL DRIVE 660 ARLINGTON VA 22202 KENNETH MENDEZ CEO/PRESIDENT 8007278462 2026-07-30 1 ADAM KUCZYNSKI CPA P01560606 7035190990 2026-07-28 2025 2025-03-06 01:10:19Z KENNETH MENDEZ 1400 CRYSTAL DRIVE 660 ARLINGTON VA 22202 7857888 0 X AAFA.ORG X 1953 NY A NATIONAL VOLUNTARY HEALTH ORGANIZATION PROVIDING EDUCATION, INFORMATION, SERVICES & RESEARCH. 21 21 29 23 0 0 4651333 5720892 1257073 1197836 280358 110745 10675 8305 6199439 7037778 419190 678155 0 0 3517499 3752784 0 0 301532 1971593 2014932 5908282 6445871 291157 591907 3525089 5449679 505516 1760075 3019573 3689604 X THE ASTHMA AND ALLERGY FOUNDATION OF AMERICA, INC (THE FOUNDATION), A NOT-FOR-PROFIT FOUNDED IN 1953, IS DEDICATED TO SAVING LIVES AND REDUCING THE BURDEN OF DISEASE FOR PEOPLE WITH ASTHMA AND ALLERGIES THROUGH SUPPORT, ADVOCACY, EDUCATION AND RESEARCH. 0 0 2229442 0 1197836 PUBLIC INFORMATION AND PATIENT, FAMILY, COMMUNITY SUPPORT:PROMOTE DISEASE AWARENESS CAMPAIGNS AND ISSUE PUBLIC HEALTH ANNOUNCEMENTS INCLUDING FOOD RECALLS, EMERGENCY AIR QUALITY INFORMATION, AND ALERTS FOR SEVERE WEATHER EVENTS THAT MAY AFFECT ASTHMA AND ALLERGY MANAGEMENT. PROVIDE DIGITAL AND PRINTED MATERIALS FOR PATIENTS, HEALTH CARE PROVIDERS, SCHOOLS, AND HEALTH DEPARTMENTS. ESTABLISH STANDARDS AND PROVIDE INFORMATION ON PRODUCTS THAT HAVE EARNED THE ASTHMA & ALLERGY FRIENDLY CERTIFICATION. PROVIDE DISEASE MANAGEMENT SUPPORT TO PATIENTS AND CAREGIVERS THROUGH PRIVATE ONLINE COMMUNITIES, REGIONAL CHAPTERS, COLLABORATIONS WITH HOSPITALS AND CLINICS, FREE ASK-THE-ALLERGIST SERVICE, TOLL FREE INFORMATION LINE, LOCAL EVENTS, AND SOCIAL MEDIA. TRAINED STAFF PROVIDE EMOTIONAL, MENTAL, AND SOCIAL SUPPORT AS WELL AS INFORMATION TO COMPLEMENT THEIR HEALTH CARE. OFFER TECHNICAL AND FINANCIAL SUPPORT TO COMMUNITY-BASED ORGANIZATIONS. 1253090 237500 0 ADVOCACY:EVALUATE FEDERAL, STATE, COUNTY, AND MUNICIPAL LEGISLATION, POLICIES, AND REGULATORY ACTIONS THAT AFFECT PEOPLE WITH ASTHMA AND ALLERGIC CONDITIONS. TRANSLATE LEGISLATIVE REVIEWS FOR PATIENTS, CLINICIANS, AND OTHER STAKEHOLDERS BY PROVIDING SUMMARIES OR REPORTS. COLLABORATE WITH COALITIONS, COMMUNITY GROUPS, AND OTHER NON-PROFIT ORGANIZATIONS TO SUPPORT HEALTHY LIVING FOR PEOPLE WITH ASTHMA AND ALLERGIES. 1044437 240655 0 PATIENT-CENTERED RESEARCHINCORPORATE PATIENT PERSPECTIVES AND PREFERENCES INTO THE DESIGN, CONDUCT, AND DISSEMINATION OF ASTHMA AND ALLERGY RESEARCH TO IMPROVE HEALTH OUTCOMES AND INFORM DECISION-MAKING. DEVELOP INTERVENTIONS THAT PRIORITIZE WHAT MATTERS MOST TO PATIENTS AND THEIR FAMILIES. RECRUIT CLINICAL TRIAL PARTICIPANTS AS WELL AS PATIENT ADVISORS FOR PATIENT-FOCUSED DRUG DEVELOPMENT. COLLECT AND ANALYZE PATIENT-REPORTED OUTCOMES; PATIENT EXPERIENCE, BEHAVIORS, PREFERENCES, KNOWLEDGE; REAL-WORLD EVIDENCE; HEALTH CARE CLAIMS DATA; AND OTHER DATA. TRANSLATE RESEARCH FINDINGS TO PATIENTS, CLINICIANS, AND OTHER STAKEHOLDERS. PUBLISH IMPACT AND BURDEN OF DISEASE REPORTS. PUBLISH MANUSCRIPTS, ABSTRACTS, WHITE PAPERS, AND POSTERS. 886542 200000 0 EDUCATION FOR HEALTH CARE PROFESSIONALS, PATIENTS, AND CAREGIVERS:OFFER ACCREDITED, CONTINUING EDUCATION FOR HEALTH CARE PROFESSIONALS (DOCTORS, PRACTITIONERS, NURSES, RESPIRATORY THERAPISTS, ASTHMA EDUCATORS, AND COMMUNITY HEALTH WORKERS) ON ASTHMA AND ALLERGY-RELATED TOPICS. PROVIDE FREE PATIENT AND CAREGIVER EDUCATION THROUGH INFORMATION PACKETS AND BOOKLETS, WEBINARS, PODCASTS, AND ONLINE COURSES. SUPPORT A NATIONAL NETWORK OF ASTHMA PROGRAMS AND EDUCATORS. OFFER ASTHMA EDUCATION PROGRAMS TO HEALTH DEPARTMENTS. 886542 200000 0 5413511 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 20 0 29 1 0 0 0 0 0 0 0 0 0 0 0 0 X 21 21 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT DE FL GA HI ID IL IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC TN TX UT VA WA WV WI WY X X KENNETH MENDEZ 8007278462 1400 CRYSTAL DRIVE STE 660 ARLINGTON VA 22202 RITESH PATEL CHAIR 2.00 X X 0 0 0 KELLI WOOD CROSS SECRETARY 2.00 X X 0 0 0 RICHARD MURRAY IMMEDIATE PAST CHAIR 2.00 X X 0 0 0 MONICA E RANDALL TREASURER & FINANCE CHAIR 2.00 X X 0 0 0 MITCHELL GRAYSON CHAIR OF MEDICAL-SCIENTIFIC COUNCIL 2.00 X 0 0 0 MARY ELLEN CONLEY CHAIR OF COMMUNITY RELATIONS 2.00 X 0 0 0 PRUE FITZPATRICK CHAIR OF POLICY & ADVOCACY 2.00 X 0 0 0 LYNN HANESSIAN CHAIR OF DEVELOPMENT 2.00 X 0 0 0 PETER LOUPOS CHAIR OF AD HOC STRATEGY 2.00 X 0 0 0 EVALYN GRANT CHAIR OF AUDIT 2.00 X 0 0 0 GORDON BUZBY CHAIR OF CERTIFICATION 2.00 X 0 0 0 TORY MATESE GENERAL COUNSEL (FROM SEPT 25) 2.00 X 0 0 0 JACOB HELLER GENERAL COUNSEL (THROUGH SEPT 25) 2.00 X 0 0 0 JODI DANIEL DIRECTOR 1.00 X 0 0 0 MEIGHAN GIRGUS VAFA DIRECTOR 1.00 X 0 0 0 EMMANUEL MAHLIS DIRECTOR 1.00 X 0 0 0 KATHERINE LAI DIRECTOR 1.00 X 0 0 0 LAWRENCE SCHWARTZ DIRECTOR 1.00 X 0 0 0 JAMES FLOOD DIRECTOR 1.00 X 0 0 0 JERRY M SHIER DIRECTOR 1.00 X 0 0 0 FOLASHADE FARRI DIRECTOR 1.00 X 0 0 0 JAMES C DOCKERY DIRECTOR 1.00 X 0 0 0 PHYLLIS ARTHUR DIRECTOR (THRU FEB 25) 1.00 X 0 0 0 KENNETH MENDEZ CEO & PRESIDENT 40.00 X 494065 0 35089 MELANIE CARVER CHIEF MISSIONS OFFICER 40.00 X 318066 0 29162 SANAZ EFTEKHARI CHIEF BUSINESS DEVELOPMENT OFFICER, VP RESEARCH 40.00 X 329552 0 7851 JENNA RIEMENSCHNEIDER VICE PRESIDENT OF ADVOCACY 40.00 X 167415 0 14089 QINGXIN CAI CONTROLLER 40.00 X 195034 0 16631 LYNNE BOSMA HEALTH EQUITY DIRECTOR 40.00 X 110326 0 0 KIMBERLY RAFFERTY MARKETING & COMMUNICATIONS 40.00 X 122598 0 16121 ELISA ZIZZA DIRECTOR OF DEVELOPMENT 40.00 X 116076 0 6965 NICOLE GAGHAN CREATIVE DIRECTOR 40.00 X 112865 0 21468 CHEYNEY TREHERNE MANAGER OF ADMINISTRATION AND GOVERNANCE 40.00 X 116458 0 13766 2082455 0 161142 13 0 1 0 M2 STRATEGIES INC 10431 EAST PRENTICE AVENUE ENGLEWOOD CO 80111 CONSULTING - ADVOCACY, EDUCATION, AND RE 115000 1 179876 5541016 5720892 CERTIFICATIONS 900099 1197836 1197836 1197836 95331 95331 835524 820110 15414 15414 15414 8305 8305 8305 7037778 1197836 0 119050 X 678155 678155 1606954 1313743 188583 104628 1694088 1384978 198809 110301 68927 56350 8089 4488 178415 145861 20938 11616 204400 167105 23987 13308 41659 41659 12637 12637 673257 592974 80108 175 144762 142260 2502 161544 122314 29615 9615 121895 110347 7478 4070 178505 145182 21735 11588 152690 123025 19482 10183 79547 66608 4303 8636 11355 9276 1341 738 54825 44713 6518 3594 DUES AND SUBSCRIPTIONS 340931 308138 26928 5865 41325 2482 38618 225 6445871 5413511 730828 301532 143481 329867 454869 1553713 554253 403972 134375 110385 10231 8951 98222 76112 80299 38424 37297 41875 1304283 1928830 607592 139122 180486 856852 3525089 5449679 350701 654488 0 157489 154815 948098 505516 1760075 X 533151 1230185 2486422 2459419 3019573 3689604 3525089 5449679 591907 78124 0 X 0 1 X 1 0 X 4861216 3876510 4808966 4651332 5720892 23918916 4861216 3876510 4808966 4651332 5720892 23918916 11141250 12777666 95658 76536 48000 68513 95331 384038 24302954 5892237 0.52580 0.51130 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 16500 11256 27756 6418115 6445871 472294 118074 0 0 438113 440094 445414 472294 1795915 2693873 12705 17736 23056 27756 81253 109528 110024 111354 118074 448980 673470 10000 10000 13500 16500 50000 400557 45368 445925 376451 24106 400557 353917 22534 376451 395760 -41843 353917 384234 17926 6400 395760 0.00000 0.35880 0.64120 0 0 48301 27097 21204 31998 11327 20671 41875 DEFERRED COMPENSATION ASSET 210253 DEPOSITS 25671 OPERATING LEASE RIGHT-OF-USE ASSET 620928 856852 DEFERRED COMPENSATION LIABILITY 210253 OPERATING LEASE LIABILITY 737845 948098 7483893 78124 380628 -12637 446115 7037778 0 7037778 6813862 380628 380628 6433234 12637 12637 6445871 PART V, LINE 4: THE FOUNDATION HAS A DONOR-RESTRICTED ENDOWMENT FUND ESTABLISHED FOR THE PURPOSE OF SUPPORTING RESEARCH BY PHYSICAN-SCIENTISTS IN THE FIELD OF ALLERGY AND IMMUNOLOGY. PART XI, LINE 2D - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENT FEES REPORTED ON FORM 990, PART IX, LINE 11F -12,637. 1 BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA BCM 225 HOUSTON TX 77030 741613878 GOVT 121405 0 FOOD ALLERGY DECISION AID RESEARCH PROJECT THE MAST CELL DISEASE SOCIETY INC PO BOX 416 STERLING MA 01564 521959601 501(C)(3) 100000 0 CSU PATIENT EDUCATION AND EMPOWERMENT CAMPAIGN WE CU 110 COUNTRYSIDE DRIVE HENDERSONVILLE TN 37075 331254259 501(C)(3) 100000 0 CSU PATIENT EDUCATION AND EMPOWERMENT CAMPAIGN UNIVERSITY OF COLORADO DENVER 1201 LARIMER ST DENVER CO 80204 846000555 GOVT 75500 0 FOOD ALLERGY DECISION AID RESEARCH PROJECT HEALTH PROMOTION COUNCIL 1500 MARKET ST PHILADELPHIA PA 19102 232182113 501(C)(3) 62500 0 HEAL INNOVATION PROGRAM YOUNG TEEN ASTHMA & WELLNESS CAMP INC 1524 SHADES CREST RD BIRMINGHAM AL 35226 861585197 501(C)(3) 60000 0 HEAL INNOVATION PROGRAM AIRNYC 349 E 149TH ST RM 609 BRONX NY 10451 132612524 501(C)(3) 50000 0 HEAL INNOVATION PROGRAM BRIGHAM AND WOMENS HOSPITAL INC 263 HUNTINGTON AVENUE 318 BOSTON MA 02115 042312909 501(C)(3) 43750 0 PATIENT-CENTERED EDUCATION AND CARE FOR NASAL POLYPS PROGRAM ASTHMA AND ALLERGY FOUNDATION OF AMERICA - MICHIGAN CHAPTER 26111 WEST 14 MILE SUITE LL1 FRANKLIN MI 48025 382534175 501(C)(3) 31250 0 HEAL INNOVATION PROGRAM THE GENERAL HOSPITAL CORPORATION 55 FRUIT ST BOSTON MA 02114 042697983 501(C)(3) 28750 0 HEAL INNOVATION PROGRAM 10 1 PART I, LINE 2: RECIPIENTS OF EACH GRANT SIGNED A MEMORANDUM OF UNDERSTANDING WITH AAFA AND OTHER DOMESTIC PARTNERS. A COUNCIL OF REPRESENTATIVES FROM AAFA AND EACH PARTNER WAS FORMED TO PROVIDE OVERSIGHT FOR THE GRANT FUNDS. X 0 0 0 0 0 0 0 0 0 KENNETH MENDEZ CEO & PRESIDENT 431029 0 63036 0 0 0 17253 0 17836 0 529154 0 0 0 MELANIE CARVER CHIEF MISSIONS OFFICER 293066 0 25000 0 0 0 14346 0 14816 0 347228 0 0 0 SANAZ EFTEKHARI CHIEF BUSINESS DEVELOPMENT OFFICER, 279552 0 50000 0 0 0 0 0 7851 0 337403 0 0 0 QINGXIN CAI CONTROLLER 175034 0 20000 0 0 0 8643 0 7988 0 211665 0 0 0 JENNA RIEMENSCHNEIDER VICE PRESIDENT OF ADVOCACY 142415 0 25000 0 0 0 6221 0 7868 0 181504 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE FEDERAL FORM 990, ONCE REVIEWED BY THE FOUNDATION'S ACCOUNTANTS, IS THEN FORWARDED TO THE FOUNDATION'S CEO AND PRESIDENT FOR REVIEW. WHEN SECONDARY REVIEW HAS BEEN COMPLETED, AND THE FEDERAL FORM 990 HAS BEEN APPROPRIATELY UPDATED OR CORRECTED, IT IS PRESENTED TO THE EXECUTIVE COMMITTEE FOR THEIR REVIEW AND APPROVAL. IT IS THEN SHARED WITH THE FULL BOARD OF DIRECTORS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY AND DISCLOSURE FORM IS DISTRIBUTED TO THE STAFF, WHICH INCLUDES OFFICERS, KEY EMPLOYEES AND HIGHEST COMPENSATED EMPLOYEES AND TO THE FULL BOARD OF DIRECTORS ANNUALLY FOR SIGNATURE REVIEW. ANY REPORTABLE CONFLICTS ARE REPORTED ON DISCLOSURE FORMS AND AT BOARD MEETINGS. DURING THE COURSE OF BOARD MEETING DISCUSSIONS, IF AREAS ARISE WHICH MAY CREATE A CONFLICT, OR THE APPEARANCE OF A CONFLICT OF INTEREST, THE BOARD OF DIRECTORS IS REMINDED OF THEIR RESPONSIBILITY TO RECUSE THEMSELVES FROM PARTICIPATION OF THE SAID MATTER. FORM 990, PART VI, SECTION B, LINE 15A ANNUALLY DURING THE BUDGET PREPARATION PROCESS, THE FINANCE COMMITTEE REVIEWS THE SALARY OF THE CEO AND PRESIDENT, AND COMPARES THE PROPOSED SALARY TO LIKE ORGANIZATIONS, POSITIONS AND GEOGRAPHIC AREAS TO RECOMMEND BUDGET APPROVAL TO THE FULL BOARD OF DIRECTORS. THE CEO AND PRESIDENT'S COMPENSATION IS APPROVED BY THE FULL BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 THE CONFLICT OF INTEREST POLICY, WHISTLEBLOWER POLICY, FINANCIAL STATEMENTS AND THE FEDERAL FORM 990 ARE AVAILABLE ON THE FOUNDATION'S WEBSITE AT WWW.AAFA.ORG. THEY MAY ALSO BE OBTAINED BY REQUEST FROM THE CEO AND PRESIDENT. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 592,974. MANAGEMENT AND GENERAL EXPENSES 80,108. FUNDRAISING EXPENSES 175. TOTAL EXPENSES 673,257.